Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System (BDDCS)

ConclusionApplication of the BDDCS to predict interactions between rifampin and antihypertensive drugs for patients with both tuberculosis and hypertension was found to be reliable. It should be noted, however, that based on the CYP enzyme and drug transporter information we reviewed, the mechanisms of all of the interactions could not be elucidated, and the predictions are only based on theory. The real effects of rifampin on antihypertensive drugs need to be further observed. Further studies in both animals and humans are needed in the future.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - February 28, 2020 Category: Drugs & Pharmacology Authors: Wei Liu, Tingting Yan, Ken Chen, Li Yang, Leslie Benet, Suodi Zhai Tags: ORIGINAL RESEARCH ARTICLE Source Type: research